- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02022943
Alzheimer's Prevention Registry: A Program to Accelerate Enrollment Into Studies (APR)
August 2, 2023 updated by: Jessica Langbaum, PhD, Banner Health
Alzheimer's Prevention Registry
The Alzheimer's Prevention Registry (www.endALZnow.org) will collect contact and demographic information on individuals.
The objective is to provide information the latest news and advances in Alzheimer's prevention research, and to inform enrollees about research studies in their community.
Enrolled individuals will receive regular email communications.
As research studies become available, individuals will be notified via email with information as to how proceed should they be interested.
Registry enrollees are under no obligation to participate in a research study.
Study opportunities may include surveys, healthy lifestyle interventions (e.g., diet, exercise), memory & thinking tests, brain scans, and investigational drug trials.
To join the Registry, please visit www.endALZnow.org
Study Overview
Status
Recruiting
Conditions
Study Type
Observational
Enrollment (Estimated)
500000
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Nellie High, MA
- Phone Number: 1-888-STOP-ALZ
- Email: info@endALZnow.org
Study Locations
-
-
Arizona
-
Phoenix, Arizona, United States, 85006
- Recruiting
- Banner Alzheimer's Institute
-
Principal Investigator:
- Jessica Langbaum, PhD
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 110 years (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Sampling Method
Non-Probability Sample
Study Population
Anyone who meets entry criteria is eligible to join the Registry.
We anticipate 250,000 individuals will join.
Description
Inclusion Criteria:
- Must be able to accept the Alzheimer's Prevention Registry website terms and conditions
Exclusion Criteria:
- None
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Number of individuals enrolled into Alzheimer's prevention studies
Time Frame: 16 years
|
16 years
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Number of individuals referred to Alzheimer's prevention research studies / sites
Time Frame: 16 years
|
16 years
|
Other Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Total number enrolled into the Alzheimer's Prevention Registry
Time Frame: 16 years
|
16 years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Jessica Langbaum, PhD, Banner Alzheimer's Institute
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Helpful Links
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
May 1, 2012
Primary Completion (Estimated)
January 1, 2030
Study Completion (Estimated)
January 1, 2030
Study Registration Dates
First Submitted
December 23, 2013
First Submitted That Met QC Criteria
December 23, 2013
First Posted (Estimated)
December 30, 2013
Study Record Updates
Last Update Posted (Actual)
August 4, 2023
Last Update Submitted That Met QC Criteria
August 2, 2023
Last Verified
August 1, 2023
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- APR
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Dementia
-
University of North Carolina, Chapel HillNational Institute on Aging (NIA)CompletedAlzheimer Dementia | Dementia Alzheimers | CaregiverUnited States
-
Temple UniversityRecruitingDementia | Mild Cognitive Impairment | Dementia, Vascular | Dementia, Mixed | Dementia Alzheimers | Mild Dementia | Dementia of Alzheimer Type | Dementia, MildUnited States
-
Hebrew SeniorLifeRecruitingAging | Alzheimer Dementia | Presenile Alzheimer DementiaUnited States
-
Temple UniversityRecruitingDementia | Alzheimer Disease | Mild Cognitive Impairment | Dementia, Vascular | Dementia, Mixed | Dementia Alzheimers | Mild Dementia | Dementia of Alzheimer Type | Dementia, MildUnited States
-
National Tainan Junior College of NursingCompletedCognitive Impairment | Dementia, Mild | Dementia ModerateTaiwan
-
Karen RobertoNational Institute on Aging (NIA)RecruitingDementia | Dementia Alzheimers | Neuro-Degenerative Disease | Dementia of Alzheimer Type | Dementia SevereUnited States
-
Cognito Therapeutics, Inc.Enrolling by invitationExtension to a Pivotal Study of Sensory Stimulation in Alzheimer's Disease (OLE Hope Study, CA-0015)Cognitive Impairment | Alzheimer Disease | Mild Cognitive Impairment | Dementia Alzheimers | Dementia of Alzheimer Type | AD | Dementia, Mild | Dementia ModerateUnited States
-
University College, LondonNot yet recruitingDementia | Dementia, Vascular | Dementia, Mixed | Dementia With Lewy Bodies | Dementia of Alzheimer Type | Dementia Moderate | Dementia Severe | Dementia Frontal | DEM
-
University College, LondonThe University of Hong KongUnknownDementia | Dementia, Vascular | Dementia, Mixed | Dementia With Lewy Bodies | Dementia of Alzheimer Type | Dementia Moderate | Dementia Severe | Dementia Frontal
-
Karolinska InstitutetRegion Stockholm; KTH Royal Institute of TechnologyActive, not recruitingAlzheimer Dementia | Dementia DisordersSweden